Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Evaluation of the Healthy LifeCheck programme: a vascular risk assessment service for community pharmacies in Leicester city, UK.

Hunt BD, Hiles SL, Chauhan A, Ighofose C, Bharakhada N, Jain A, Davies MJ, Khunti K.

J Public Health (Oxf). 2013 Sep;35(3):440-6. doi: 10.1093/pubmed/fdt017. Epub 2013 Mar 11.

PMID:
23479477
2.

Evaluation of a cardiovascular disease opportunistic risk assessment pilot ('Heart MOT' service) in community pharmacies.

Horgan JM, Blenkinsopp A, McManus RJ.

J Public Health (Oxf). 2010 Mar;32(1):110-6. doi: 10.1093/pubmed/fdp092. Epub 2009 Oct 28.

PMID:
19864496
3.

Widening access to cardiovascular healthcare: community screening among ethnic minorities in inner-city Britain - the Healthy Hearts Project.

Patel JV, Gunarathne A, Lane D, Lim HS, Tracey I, Panja NC, Lip GY, Hughes EA.

BMC Health Serv Res. 2007 Nov 23;7:192.

4.

A pilot study evaluating multiple risk factor interventions by community pharmacists to prevent cardiovascular disease: the PAART CVD pilot project.

McNamara KP, O'Reilly SL, Dunbar JA, Bailey MJ, George J, Peterson GM, Jackson SL, Janus ED, Bunker S, Duncan G, Howarth H.

Ann Pharmacother. 2012 Feb;46(2):183-91. doi: 10.1345/aph.1Q572. Epub 2012 Feb 7.

PMID:
22318928
5.

The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.

Puspitasari HP, Aslani P, Krass I.

Int J Clin Pharm. 2015 Oct;37(5):834-43. doi: 10.1007/s11096-015-0127-y. Epub 2015 May 12.

PMID:
25964140
6.

Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial.

Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, Sargeant LA, Williams KM, Prevost AT, Kinmonth AL, Wareham NJ, Griffin SJ.

Lancet. 2012 Nov 17;380(9855):1741-8. doi: 10.1016/S0140-6736(12)61422-6. Epub 2012 Oct 4.

7.

Effectiveness of a national cardiovascular disease risk assessment program (NHS Health Check): results after one year.

Artac M, Dalton AR, Majeed A, Car J, Millett C.

Prev Med. 2013 Aug;57(2):129-34. doi: 10.1016/j.ypmed.2013.05.002. Epub 2013 May 21.

PMID:
23701848
8.
9.

Effectiveness of Dader Method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial.

Amariles P, Sabater-Hernández D, García-Jiménez E, Rodríguez-Chamorro MÁ, Prats-Más R, Marín-Magán F, Galán-Ceballos JA, Jiménez-Martín J, Faus MJ.

J Manag Care Pharm. 2012 May;18(4):311-23.

10.

A feasibility study of community pharmacists performing depression screening services.

O'Reilly CL, Wong E, Chen TF.

Res Social Adm Pharm. 2015 May-Jun;11(3):364-81. doi: 10.1016/j.sapharm.2014.08.013. Epub 2014 Sep 28.

PMID:
25438728
11.

Community pharmacy-based implementation and evaluation of an osteoporosis self-assessment tool for Asians.

Chaiyakunapruk N, Laowakul A, Karnchanarat S, Pikulthong N, Ongphiphadhanakul B.

J Am Pharm Assoc (2003). 2006 May-Jun;46(3):391-6.

PMID:
16739762
12.
13.

Evaluation of community provision of a preventive cardiovascular programme - the National Health Service Health Check in reaching the under-served groups by primary care in England: cross sectional observational study.

Woringer M, Cecil E, Watt H, Chang K, Hamid F, Khunti K, Dubois E, Evason J, Majeed A, Soljak M.

BMC Health Serv Res. 2017 Jun 14;17(1):405. doi: 10.1186/s12913-017-2346-5.

15.

Record-based, stepwise screening for type 2 diabetes integrated into an annual cardiovascular care review system: Findings from a UK general practice.

Fisher BG, Ang YL, Goodhart C, Simmons RK.

Prim Care Diabetes. 2011 Dec;5(4):265-9. doi: 10.1016/j.pcd.2011.09.001. Epub 2011 Oct 2.

PMID:
21968319
16.

Prevalence of cardiovascular disease risk amongst the population eligible for the NHS Health Check Programme.

Dalton AR, Soljak M, Samarasundera E, Millett C, Majeed A.

Eur J Prev Cardiol. 2013 Feb;20(1):142-50. doi: 10.1177/1741826711428797. Epub 2011 Nov 4.

PMID:
22058079
17.

How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.

Saramunee K, Krska J, Mackridge A, Richards J, Suttajit S, Phillips-Howard P.

Res Social Adm Pharm. 2014 Mar-Apr;10(2):272-84. doi: 10.1016/j.sapharm.2012.05.006. Epub 2012 Oct 23.

PMID:
23089293
18.

Coverage of a national cardiovascular risk assessment and management programme (NHS Health Check): Retrospective database study.

Chang KC, Soljak M, Lee JT, Woringer M, Johnston D, Khunti K, Majeed A, Millett C.

Prev Med. 2015 Sep;78:1-8. doi: 10.1016/j.ypmed.2015.05.022. Epub 2015 Jun 4.

PMID:
26051202
19.

Alcohol brief intervention in community pharmacies: a feasibility study of outcomes and customer experiences.

Khan NS, Norman IJ, Dhital R, McCrone P, Milligan P, Whittlesea CM.

Int J Clin Pharm. 2013 Dec;35(6):1178-87. doi: 10.1007/s11096-013-9845-1. Epub 2013 Sep 8.

PMID:
24013957
20.

Analysis of primary prevention services for cardiovascular disease in Australia's community pharmacies.

Joyce A, Berbatis CG, Sunderland VB, Dhaliwal SS.

Aust N Z J Public Health. 2007 Dec;31(6):516-9.

PMID:
18081569

Supplemental Content

Support Center